1. Home
  2. MKTW vs ADVM Comparison

MKTW vs ADVM Comparison

Compare MKTW & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKTW
  • ADVM
  • Stock Information
  • Founded
  • MKTW 1999
  • ADVM 2006
  • Country
  • MKTW United States
  • ADVM United States
  • Employees
  • MKTW N/A
  • ADVM N/A
  • Industry
  • MKTW Computer Software: Prepackaged Software
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MKTW Technology
  • ADVM Health Care
  • Exchange
  • MKTW Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • MKTW 48.2M
  • ADVM 49.9M
  • IPO Year
  • MKTW N/A
  • ADVM 2014
  • Fundamental
  • Price
  • MKTW $19.69
  • ADVM $2.45
  • Analyst Decision
  • MKTW
  • ADVM Strong Buy
  • Analyst Count
  • MKTW 0
  • ADVM 5
  • Target Price
  • MKTW N/A
  • ADVM $23.80
  • AVG Volume (30 Days)
  • MKTW 12.7K
  • ADVM 113.1K
  • Earning Date
  • MKTW 08-07-2025
  • ADVM 08-11-2025
  • Dividend Yield
  • MKTW 4.20%
  • ADVM N/A
  • EPS Growth
  • MKTW 207.28
  • ADVM N/A
  • EPS
  • MKTW 3.12
  • ADVM N/A
  • Revenue
  • MKTW $383,217,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • MKTW N/A
  • ADVM N/A
  • Revenue Next Year
  • MKTW N/A
  • ADVM $18.82
  • P/E Ratio
  • MKTW $6.09
  • ADVM N/A
  • Revenue Growth
  • MKTW N/A
  • ADVM N/A
  • 52 Week Low
  • MKTW $9.08
  • ADVM $1.78
  • 52 Week High
  • MKTW $21.74
  • ADVM $8.56
  • Technical
  • Relative Strength Index (RSI)
  • MKTW 55.26
  • ADVM 49.55
  • Support Level
  • MKTW $17.97
  • ADVM $2.27
  • Resistance Level
  • MKTW $21.74
  • ADVM $2.58
  • Average True Range (ATR)
  • MKTW 1.05
  • ADVM 0.19
  • MACD
  • MKTW -0.12
  • ADVM -0.02
  • Stochastic Oscillator
  • MKTW 45.49
  • ADVM 35.86

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: